NIA and EuropaBio are pleased to host a joint webinar that present the opportunities and development pathways within nanomedicine.

Members from both networks will come together to understand how nanomaterials play a role across healthcare biotechnology applications, with examples of nanomedicines in development and clinical application.  The webinar will also explore when regulatory worlds come together with healthcare and nano, and highlight funding opportunities for organisations to work together in developing novel nanomedicines.

A number of H2020 funded projects are working on various aspects of the Safe-by-Design (SbD) concept and all rely upon industry to understand its meaning and how to use the tools being developed in these projects. Disseminating this knowledge to a wider audience will help in the acceptance and uptake of SbD by companies and will also allow the projects to learn more about stakeholder needs.

Building on the success of the 2015 symposium held at Legend Safari Lodge, Limpopo Province, South Africa, this conference will also bring together a multidisciplinary cross section of delegates from different scientific areas specializing in all aspects of nanosafety.

The NIA kick starts its Funding Tracker for members with a 60 minute webinar.  This opening meeting will review funding tools that suit nanotechnology research and commercial development.  It will support all NIA members, including SMEs, research centres and large companies.

In the long term, the Funding Tracker will support NIA members to identify the most suitable tools for them, focus on project ideas and help build partnerships for a successful collaboration.